Gabapentin
Product Images NDC 67046-703

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 67046-703). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gab (Gab400.703)

A pharmaceutical label for Gabapentin 400 mg tablets, packaged in a bottle of 30 tablets. The label includes the Contract Pharmacy Services-PA labeler information, storage instructions at controlled room temperature (20-25°C), barcode, and a note to see accompanying prescribing information for dosage details.*

FDA Label Image

1 (Image 1)

An illustration of the formula to estimate creatinine clearance (CLCr), indicating adjustments for age, weight, sex, and serum creatinine levels in mg/dL.*

FDA Label Image

1 (Image 10)

Gabapentin oral solution bottle label from Contract Pharmacy Services-PA. The label includes the proprietary name Gabapentin and shows directions for use, concentration, and other pharmaceutical details. The bottle appears to have a child-resistant cap and a measuring device for dosing.*

FDA Label Image

1 (Image 11)

Gabapentin vial with a white cap and a label wrapped around it. The label includes the product name Gabapentin and the NDC number 67046-703, with Contract Pharmacy Services-PA indicated as the labeler. No strength or volume is visible on the vial in the image.*

FDA Label Image

1 (Image 12)

Gabapentin capsules in a transparent blister pack with seven capsules visible. The capsules have light and dark segments but no visible numeric or text imprint. No packaging box or additional labeling information is shown.*

FDA Label Image

1 (Image 2)

Gabapentin oral tablets packaging labeled with proprietary name Gabapentin. The label includes a bottle with a white cap and a white and blue label. The product is provided by Contract Pharmacy Services-PA. No strength, dosage form, or package count is visible in the image.*

FDA Label Image

1 (Image 3)

Gabapentin 600 mg capsules blister pack from Contract Pharmacy Services-PA. The image shows a horizontal strip with three blue and white hard gelatin capsules, each containing the active ingredient gabapentin at 600 mg strength. The capsules are partially visible through a transparent blister sheet on a silver backing.*

FDA Label Image

1 (Image 4)

Gabapentin vial reverse label showing detailed drug information, including barcode, lot number, and manufacturer details for Contract Pharmacy Services-PA. The label is primarily white with blue and black text.*

FDA Label Image

1 (Image 5)

Chemical structure of Gabapentin, showing a cyclohexane ring attached to amino (CH2NH2) and carboxymethyl (CH2CO2H) groups.*

FDA Label Image

1 (Image 6)

A line graph showing mean pain scores over 8 weeks comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks, including a 4-week dose titration period followed by a 4-week fixed dose period, while the y-axis measures mean pain score from 0 to 10. Gabapentin shows a notable decrease in pain scores over time compared to placebo.*

FDA Label Image

2 (Image 7)

A line graph showing mean pain scores over seven weeks for three groups: placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks including a 3-week dose titration and a 4-week fixed dose period, while the y-axis represents mean pain scores from 0 to 10. The graph illustrates a decrease in pain scores for both Gabapentin doses compared to placebo over time.*

FDA Label Image

3 (Image 8)

A bar chart comparing percentage outcomes for placebo (PBO) versus Gabapentin (GBP) at different dosages across two studies. Study 1 shows 12% for PBO and 29% for GBP 3600. Study 2 shows 14% for PBO, 32% for GBP 1800, and 34% for GBP 2400. Statistical significance is indicated for GBP bars with p-values less than 0.01 and 0.001.*

FDA Label Image

4 (Image 9)

A scatter plot showing the relationship between daily dose (mg) on the x-axis and difference (%) on the y-axis for Gabapentin. It compares results from three studies labeled as Study a, Study b, and Study c, each represented by different colored squares, across daily doses of approximately 600, 900, 1200, and 1800 mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.